A tissue culture cell system for isolation and identification of members of the murine leukemia virus group (the complement fixation for murine leukemia test) was modified to permit the isolation of naturally occurring virus from leukemic and normal mice. The important factors for increasing the sensitivity of the test were the use of National Institutes of Health (NIH) strain Webster Swiss embryo cell cultures and the selection of rat-immune sera having complement-fixing antibodies to tissue culture antigens of both the Gross and FMR subgroups. In all, 163 strains of mouse leukemia virus, from 11 inbred mouse strains, have been isolated. Representative virus isolates were shown to possess the properties of the murine leukemia virus group; i.e., they were chloroform-sensitive, noncytopathic agents which replicated in mouse embryo tissue culture and produced group-reactive, complementfixing antigen and budding C-type particles visible by electron microscopy. These viruses could serve as helpers in the rescue of Moloney sarcoma virus genome from non-producer hamster sarcoma cells, yielding pseudotypes. All of the 19 field isolates tested were neutralized by Gross passage A antiserum but not by potent antisera to the Moloney, Rauscher, and Friend strains. Virus was recovered regularly from embryos and from the plasma and spleen of adult mice of high leukemic strains. In low leukemic mouse strains, different patterns of virus detection were observed. In C3H/He mice, virus was occasionally present in embryos and was found in 40% of adult spleens. BALB/c mice were virus-negative as fetuses or weanlings, but spleens of more than half of the mice over 6 months of age yielded virus. NIH mice have never yielded virus. In reciprocal matings between AKR and BALB/c mice, virus recovery from embryos was maternally determined. The development of tissue culture isolation procedures made possible for the first time the application of classical infectious disease methods to the study of the natural history of murine leukemia virus infection.
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It has been known for a number of years that laboratory strains of murine leukemia virus (MuLV) can be propagated in cell cultures (7, 12, 21, 24, 25, 27, 29, (32) (33) (34) (35) (36) Tissue cultures. Primary mouse embryo tissue cultures (NIH-METC) were prepared as previously described (14) by trypsinization of minced 14-to 17-day NIH Swiss embryos; generally, embryos from several mothers were pooled. Inoculations for virus isolation and assay tests were made in 1-day-old secondary plate cultures (60-mm dishes, Falcon Plastic, Inc., Los Angeles, Calif.) seeded with 350,000 cells. Virus and CF antigen pools were prepared by infecting 32-oz (0.946-liter) bottle cultures seeded the previous day with 4 X 106 cells. All cultures were grown and maintained with twice weekly fluid changes in 10% unheated fetal calf serum in EMEM with 2 mM glutamine, and were held in a humidified atmosphere containing 5% CO2 at 36 C.
CF tests. CF determinations were done in the microtiter system, with 1.8 units of complement, as previously described (17) . Serum pools were routinely used for testing unknown tissue culture antigens at a dilution containing 4 to 8 units of CF antibody.
Production of antisera. Rat antisera used in the CF test were obtained from animals bearing transplanted tumors induced with MuLV or the Moloney strain of murine sarcoma virus (M-MSV; 23). For most of the tests reported here, sera were obtained from inbred Fischer rats carrying transplanted sarcomas induced by M-MSV. Weanling rats were inoculated subcutaneously with small amounts of minced tumor tissue and were bled as late as possible after development of the tumor.
The procedure for evaluating sera for inclusion in pools was as follows. Individual sera were titrated in CF against four to eight units of Moloney and Gross passage A antigens prepared in tissue culture. Those sera titering 1:160 or greater against the latter were further tested for the ability of a 1:40 dilution to detect four units of antigen in tests against a battery of tissue culture-antigen preparations including Rauscher, Moloney, Gross passage A, and AKR viruses; the sera were also screened at a 1:20 dilution against a battery of control antigens, consisting of normal rat thymus, normal NIH mouse spleen, and control NIH-METC. In contrast to the sera from noninbred rats used in earlier studies (14) , sera prepared in inbred Fischer rats almost never reacted with control antigens. Sera which showed satisfactory titer, specificity, and sensitivity for detecting antigen were pooled; these pools were referred to here as broadly reactive serum pools.
Several points should be noted concerning the production and testing of antisera. For the most part, obtaining suitable broadly reactive sera has been a difficult and inefficient process. Less than 1% of the rats bearing transplants of lymphomas induced with Gross passage A or Rauscher viruses yielded suitable sera; hyperimmunization with tissue culture virus gave a similarly low frequency of adequate response. However, a higher frequency of broad response was found in recipients of the M-MSV transplanted sarcoma.
An important factor in obtaining sufficiently long survival of the tumor-bearing animals for broad antibody response to occur was the use of tumor lines carried in suckling rats rather than in older animals for inoculation of weanlings for antiserum production.
The broadly reactive serum pools showed groupspecific reactivity with both soluble and sedimentable (15,000 X g, 1 hr) fractions of MuLV antigens (15) . It should be noted that the rat antiserum used by Geering et al. (6) to demonstrate group-reactive antigens in immunodiffusion tests with ether-treated virus showed high-titer broad reactivity in CF tests in our laboratory (this serum was kindly supplied by Lloyd J. Old).
Although we found that CF antibody to MuLV occurs in the sera of many normal, retired breeder rats (30) , this did not appear to be a contributory factor in the antibodies studied here, since the naturally occurring antibodies were not broadly reactive and were present chiefly in sera of rats much older than those used for antiserum production.
Virus and CF antigen pools. To produce pools of infectious virus, cultures were harvested 16 to 21 
RESULTS
Isolation of virus from mice of various strains. Table 1 summarizes our findings when materials from normal and leukemic uninoculated mice were tested. The data represent tests of individual mice and pooled tissues from 2 to 5 animals, the majority of tests being of individual animals.
Except for the tests of embryo cells, all isolations are based on recovery of virus in NIH-METC. Virus was recovered regularly from the embryos, plasma, and normal and leukemic tissues of strains of mice with a high incidence of spontaneous leukemia. In the strains with a low leukemia incidence, greater variation in the patterns of virus recovery was seen. In C3H/He mice, virus was detected in embryos and adult tissues, but not as regularly as in high leukemic mice. BALB/c embryos did not yield virus, but the spleens of retired breeders were frequently positive. NIH Swiss mice were consistently negative in all tests. In no instance was a difference in the frequency of virus recovery seen between mice of the same strain raised in different colonies.
The sensitivity of different tests for detecting virus in fetal cells is shown in (Table 3 ). The field strains were chloroform-sensitive (10%, 10 min at 4 C) and did not react in CF against four to eight units of antibody against other mouse and rat viruses, including lymphocytic choriomeningitis, mouse hepatitis, Sendai, mouse adenovirus, minute virus of mice, polyoma, K, reovirus, Theiler's GDVII, Kilham rat virus, H-1 and SV5.
The field isolates shown in Table 3 , as well as nine other strains from AKR, C58, BALB/c, CF-1, and CFW mice, were tested for neutralization by rat antisera to Gross passage A, Moloney, Friend, and Rauscher viruses. All were neutralized by the Gross antiserum, and not by the FMR subgroup antisera.
Examination of infected NIH-METC cells for particles detectable by electron microscopy was kindly carried out by Walter B. Becker, M. David Hoggan, and Jane Dees. Flask cultures were infected with undiluted virus and were maintained foi 16 days; a portion of the cell sheet was then harvested in the usual manner to confirm that CF antigen was present, and the remainder was fixed with glutaraldehyde and osmium tetroxide, embedded in Epon, and sectioned. The sections were stained with lead citrate and were observed in a Siemens electron microscope. Numerous C-type particles, budding from plasma membranes and free in intercellular spaces, were observed in all inoculated cultures. Uninoculated cells from the same test were negative for CF antigen and particles; in addition, William T. Hall examined sections of three lots of control NIH-METC, with negative results.
Like the Rauschet, Moloney, Friend, and Gross passage A strains of MuLV (15, 16) , all field isolates tested were capable of serving as helper viruses for the rescue of the sarcomagenic marker in nonproducer MSV hamster tumor cells. Fluids from mixed cultures of NIH-METC and HT-1 cells infected with tissue culture passage viruses induced typical foci in NIH-METC. Newborn NIH mice inoculated with such fluids or with harvests from focus-containing NIH-METC cultures developed sarcomata essentially indistinguishable from those induced by M-MSV, and extracts prepared from the tumors induced typical foci in tissue culture.
The vaiious tissue culture isolates were not tested extensively for leukemogenic activity. In a preliminary test in rats, trypsinized NIH-METC of which have been recovered from laboratory passage material (5, 22, 26, 28) , remains obscure.
The NIH-METC system reported here has permitted the isolation and laboratory study of a wide variety of strains from naturally infected animals, but is not sensitive to all strains of virus. The most notable example is the virus recovered by Kaplan from C57B1 leukemia (20) , which does not induce antigen in NIH-METC, even though the MuLV group antigen is present in the leukemic tissues (30) . Also, as mentioned above, we have recently recovered some field strains from tumored BALB/c mice with a distinctly different host range in METC.
Sources of Swiss mice, other than the NIH strain, have not been fully evaluated for their sensitivity for the isolation of naturally occurring viruses of the MuLV group, nor have we evaluated a wide variety of inbred mouse strains. It should be emphasized that in choosing a source of embryos for the tissue culture indicator system, selection must be based not only on sensitivity but on absence of endogenous virus. In view of the frequent presence of leukemia virus in embryo cultures of certain mouse strains reported here, the choice is clearly limited.
The finding that field isolates grown in tissue culture could be employed in the recovery of MSV pseudotypes should facilitate the serological characterization of naturally occurring MuLV, since the antigenic nature of a pseudotype is that of the helper virus (15, 16) .
